Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.
Clinical trial NCT07152366 · RECRUITING
Trial details
- NCT number
- NCT07152366
- Sponsor
- Shanghai Changzheng Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-15
- Primary completion
- 2027-05-31
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.